<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AAsset_valuation</id>
	<title>Definition:Asset valuation - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AAsset_valuation"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Asset_valuation&amp;action=history"/>
	<updated>2026-06-14T21:10:40Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Asset_valuation&amp;diff=12581&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Asset_valuation&amp;diff=12581&amp;oldid=prev"/>
		<updated>2026-03-13T11:56:03Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📊 &amp;#039;&amp;#039;&amp;#039;Asset valuation&amp;#039;&amp;#039;&amp;#039; is the process by which [[Definition:Insurance carrier | insurers]] and [[Definition:Reinsurance | reinsurers]] determine the fair or regulatory value of the investments and other assets held on their [[Definition:Balance sheet | balance sheets]]. Unlike many other industries where asset valuation is primarily an accounting exercise, insurance companies face unique constraints because the value assigned to their assets directly affects their [[Definition:Solvency | solvency]] position, [[Definition:Regulatory capital | capital adequacy]], and capacity to pay future [[Definition:Claim | claims]]. Regulators worldwide impose specific valuation rules that may differ significantly from general accounting standards, reflecting the critical public interest in ensuring that policyholders are protected.&lt;br /&gt;
&lt;br /&gt;
⚙️ The mechanics of asset valuation vary considerably across regulatory regimes. In the United States, the [[Definition:National Association of Insurance Commissioners (NAIC) | NAIC]] prescribes [[Definition:Statutory accounting | statutory accounting principles]] (SAP) under which certain assets may be carried at amortized cost rather than market value, and some assets are classified as &amp;quot;non-admitted&amp;quot; and excluded from the balance sheet entirely. Under [[Definition:Solvency II | Solvency II]] in Europe, assets are generally valued on a market-consistent basis, aligning more closely with [[Definition:International Financial Reporting Standards (IFRS) | IFRS]] fair value principles. China&amp;#039;s [[Definition:C-ROSS | C-ROSS]] framework applies its own tiered approach, and Japan&amp;#039;s Financial Services Agency maintains distinct valuation standards for domestic insurers. Beyond regulatory reporting, insurers also perform internal asset valuations for [[Definition:Investment management | investment management]], [[Definition:Asset-liability management (ALM) | asset-liability management]], and [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] due diligence, where the approach may blend market pricing, discounted cash flow models, and independent appraisals.&lt;br /&gt;
&lt;br /&gt;
💡 Getting asset valuation right has profound downstream consequences for an insurer&amp;#039;s financial health and strategic flexibility. Overstated asset values can mask underlying [[Definition:Insolvency | insolvency]] risk, while overly conservative valuations may tie up [[Definition:Surplus | surplus]] that could otherwise support [[Definition:Underwriting | underwriting]] growth or shareholder distributions. The [[Definition:Asset valuation reserve (AVR) | asset valuation reserve]] required by U.S. regulators, for instance, exists specifically to cushion against credit and market fluctuations in an insurer&amp;#039;s investment portfolio. In an era of volatile interest rates and expanding insurer allocations to alternative assets such as [[Definition:Private equity | private equity]] and [[Definition:Asset-backed security | asset-backed securities]], the rigor and transparency of asset valuation practices have come under increasing scrutiny from regulators, [[Definition:Rating agency | rating agencies]], and investors alike.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Asset-liability management (ALM)]]&lt;br /&gt;
* [[Definition:Statutory accounting]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:Asset valuation reserve (AVR)]]&lt;br /&gt;
* [[Definition:Regulatory capital]]&lt;br /&gt;
* [[Definition:Investment management]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>